These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 22169272

  • 1. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
    Trottier J, Białek A, Caron P, Straka RJ, Heathcote J, Milkiewicz P, Barbier O.
    Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
    [Abstract] [Full Text] [Related]

  • 2. Serum bile acids in primary biliary cirrhosis.
    Bloomer JR, Allen RM, Klatskin G.
    Arch Intern Med; 1976 Jan; 136(1):57-61. PubMed ID: 1247336
    [Abstract] [Full Text] [Related]

  • 3. Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis.
    Rudolph G, Endele R, Senn M, Stiehl A.
    Hepatology; 1993 Jun; 17(6):1028-32. PubMed ID: 8514251
    [Abstract] [Full Text] [Related]

  • 4. Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease.
    Azer SA, Coverdale SA, Byth K, Farrell GC, Stacey NH.
    J Gastroenterol Hepatol; 1996 Mar; 11(3):208-15. PubMed ID: 8742915
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of cholestatic liver disease].
    Pleşa A.
    Rev Med Chir Soc Med Nat Iasi; 2003 Mar; 107(4):733-6. PubMed ID: 14756010
    [Abstract] [Full Text] [Related]

  • 6. Selectivity and sensitivity of changes in serum bile acids during induction of cirrhosis in rats.
    Azer SA, Murray M, Farrell GC, Stacey NH.
    Hepatology; 1993 Nov; 18(5):1224-31. PubMed ID: 8225229
    [Abstract] [Full Text] [Related]

  • 7. Serum bile acid concentration after a test meal.
    Fausa O.
    Scand J Gastroenterol; 1976 Nov; 11(3):229-32. PubMed ID: 1273500
    [Abstract] [Full Text] [Related]

  • 8. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE.
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [Abstract] [Full Text] [Related]

  • 9. Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis.
    Wunsch E, Trottier J, Milkiewicz M, Raszeja-Wyszomirska J, Hirschfield GM, Barbier O, Milkiewicz P.
    Hepatology; 2014 Sep; 60(3):931-40. PubMed ID: 24519384
    [Abstract] [Full Text] [Related]

  • 10. Plasma antioxidant levels in chronic cholestatic liver diseases.
    Floreani A, Baragiotta A, Martines D, Naccarato R, D'odorico A.
    Aliment Pharmacol Ther; 2000 Mar; 14(3):353-8. PubMed ID: 10735930
    [Abstract] [Full Text] [Related]

  • 11. Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic.
    Davies YK, Cox KM, Abdullah BA, Safta A, Terry AB, Cox KL.
    J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):61-7. PubMed ID: 18607270
    [Abstract] [Full Text] [Related]

  • 12. Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases.
    Cabibi D, Tarantino G, Barbaria F, Campione M, Craxì A, Di Marco V.
    Dig Liver Dis; 2010 Aug; 42(8):585-92. PubMed ID: 20060371
    [Abstract] [Full Text] [Related]

  • 13. Serum concentrations of 7alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans.
    Sauter G, Berr F, Beuers U, Fischer S, Paumgartner G.
    Hepatology; 1996 Jul; 24(1):123-6. PubMed ID: 8707250
    [Abstract] [Full Text] [Related]

  • 14. [Activity of neutral endopeptidase in serum of patients with primary biliary cirrhosis].
    Horvát-Karajz K, Csepregi A, Nemesánszky E, Tulassay Z, Selmeci L, Szalay F.
    Orv Hetil; 2000 Apr 30; 141(18):963-5. PubMed ID: 10832380
    [Abstract] [Full Text] [Related]

  • 15. Recognizing primary biliary cirrhosis and primary sclerosing cholangitis.
    Buckley SE, DiPalma JA.
    Am Fam Physician; 1996 Jan 30; 53(1):195-200. PubMed ID: 8546046
    [Abstract] [Full Text] [Related]

  • 16. Ursocholic acid, a hydrophilic bile acid, fails to improve liver function parameters in primary biliary cirrhosis: comparison with ursodeoxycholic acid.
    Batta AK, Salen G, Abroon J.
    Am J Gastroenterol; 1997 Jun 30; 92(6):1035-7. PubMed ID: 9177526
    [Abstract] [Full Text] [Related]

  • 17. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial.
    Beuers U, Spengler U, Kruis W, Aydemir U, Wiebecke B, Heldwein W, Weinzierl M, Pape GR, Sauerbruch T, Paumgartner G.
    Hepatology; 1992 Sep 30; 16(3):707-14. PubMed ID: 1505913
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis.
    Adams DH, Hubscher SG, Shaw J, Johnson GD, Babbs C, Rothlein R, Neuberger JM.
    Hepatology; 1991 Sep 30; 14(3):426-31. PubMed ID: 1714872
    [Abstract] [Full Text] [Related]

  • 19. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
    Sakisaka S, Kawaguchi T, Taniguchi E, Hanada S, Sasatomi K, Koga H, Harada M, Kimura R, Sata M, Sawada N, Mori M, Todo S, Kurohiji T.
    Hepatology; 2001 Jun 30; 33(6):1460-8. PubMed ID: 11391535
    [Abstract] [Full Text] [Related]

  • 20. [No complaints, but constantly elevated cholestatic serum liver tests].
    Kherbèche H.
    Praxis (Bern 1994); 2011 Jul 06; 100(14):865-7. PubMed ID: 21732301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.